• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨保护素作为老年衰弱综合征的生物标志物。

Osteoprotegerin as a biomarker of geriatric frailty syndrome.

作者信息

Valentini Alessia, Cianfarani Maria Assunta, Tarantino Umberto, Di Daniele Nicola, Bertoli Aldo

机构信息

Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Department of Orthopaedics and Traumatology, University of Rome "Tor Vergata", 00133 Rome, Italy.

出版信息

Aging (Albany NY). 2019 Jul 17;11(14):4900-4909. doi: 10.18632/aging.102083.

DOI:10.18632/aging.102083
PMID:31311890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6682533/
Abstract

The lack of a univocal definition of frailty, a condition frequently found in the elderly population which is correlated with an increased risk of mortality, has prompted the search for clinical and laboratory parameters associated with this condition. Whereas OPG is a protein involved in different pathophysiological conditions including bone, vascular, immune and tumor disease and studies found a positive linear correlation between OPG and age we hypothesized that it may represent a frailty marker in the elderly.We conducted an observational study of 172 elderly subjects, with and without hip fracture, including a multidimensional geriatric evaluation and a laboratory evaluation, aimed to evaluate the association between OPG and frailty.Frailty Score was associated with FT3 and osteoprotegerin (OPG), regardless of fracture event. Excluding subjects with hip fracture, in whom the acute event had a direct effect on bone production of OPG, the Frailty Score showed a linear correlation with circulating levels of osteoprotegerin.In the elderly, an increase in osteoprotegerin levels may reflect a progressive accumulation of organ damage leading to the development of frailty. The correlation between OPG and Frailty Score found in our study points to its potential use as a biomarker for geriatric frailty syndrome.

摘要

衰弱缺乏统一的定义,这是一种在老年人群中经常出现的状况,与死亡风险增加相关,这促使人们寻找与该状况相关的临床和实验室参数。骨保护素(OPG)是一种参与包括骨骼、血管、免疫和肿瘤疾病在内的不同病理生理状况的蛋白质,并且研究发现OPG与年龄之间存在正线性相关,我们推测它可能是老年人衰弱的一个标志物。我们对172名有或无髋部骨折的老年受试者进行了一项观察性研究,包括多维老年评估和实验室评估,旨在评估OPG与衰弱之间的关联。衰弱评分与游离三碘甲状腺原氨酸(FT3)和骨保护素(OPG)相关,无论是否发生骨折事件。排除髋部骨折患者(在这些患者中急性事件对OPG的骨生成有直接影响)后,衰弱评分与骨保护素的循环水平呈线性相关。在老年人中,骨保护素水平的升高可能反映了器官损伤的逐渐积累,导致衰弱的发展。我们研究中发现的OPG与衰弱评分之间的相关性表明其有可能用作老年衰弱综合征的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/007f6640879b/aging-11-102083-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/58f0f15acc27/aging-11-102083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/a46e22ff2b50/aging-11-102083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/fa2e6183c316/aging-11-102083-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/007f6640879b/aging-11-102083-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/58f0f15acc27/aging-11-102083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/a46e22ff2b50/aging-11-102083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/fa2e6183c316/aging-11-102083-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7229/6682533/007f6640879b/aging-11-102083-g004.jpg

相似文献

1
Osteoprotegerin as a biomarker of geriatric frailty syndrome.骨保护素作为老年衰弱综合征的生物标志物。
Aging (Albany NY). 2019 Jul 17;11(14):4900-4909. doi: 10.18632/aging.102083.
2
Low FT3: a possible marker of frailty in the elderly.低游离三碘甲状腺原氨酸:老年人虚弱的一个可能标志物。
Clin Interv Aging. 2017 Feb 10;12:335-341. doi: 10.2147/CIA.S125934. eCollection 2017.
3
Osteoprotegerin in diabetic osteopathy.护骨素在糖尿病性骨病中的作用。
Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):49-55. doi: 10.1016/j.numecd.2019.08.018. Epub 2019 Sep 9.
4
Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.瑞典75岁及以上新发髋部骨折老年患者与健康对照者血清中骨转换标志物Dickkopf-1、硬化蛋白、骨保护素、骨桥蛋白、骨钙素和25-羟基维生素D的水平。
J Endocrinol Invest. 2016 Aug;39(8):855-63. doi: 10.1007/s40618-015-0421-5. Epub 2016 Feb 5.
5
Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?血清铁蛋白升高和循环骨保护素水平作为因脆性骨折入院的绝经后女性髋部骨折的独立预测因素:是时候采用新的筛查策略了吗?
Immunol Res. 2017 Feb;65(1):423-427. doi: 10.1007/s12026-016-8849-z.
6
The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients.血清 RANKL/OPG 比值在老年患者股骨转子间骨折愈合中的作用。
Mol Med Rep. 2013 Apr;7(4):1169-72. doi: 10.3892/mmr.2013.1335. Epub 2013 Feb 21.
7
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.测量老年女性骨代谢中核因子-κB 受体活化因子配体和骨保护素的可溶性受体的意义
Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22.
8
Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status?血清护骨素水平与维生素 D 状态低下的老年女性脆性骨折有关吗?
Med Sci Monit. 2010 Feb;16(2):CR96-101.
9
Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD.循环骨保护素与慢性阻塞性肺疾病患者的髋部骨质疏松症有关。
Respir Med. 2014 Apr;108(4):621-7. doi: 10.1016/j.rmed.2013.12.011. Epub 2013 Dec 31.
10
Osteoprotegerin: a new biomarker for impaired bone metabolism in complex regional pain syndrome?骨保护素:复杂区域疼痛综合征中骨代谢受损的一种新生物标志物?
Pain. 2014 May;155(5):889-895. doi: 10.1016/j.pain.2014.01.014. Epub 2014 Jan 18.

引用本文的文献

1
Challenges in Identifying Biomarkers of Frailty Syndrome: A Systematic Review.衰弱综合征生物标志物识别中的挑战:一项系统综述
Medicina (Kaunas). 2025 Jul 21;61(7):1309. doi: 10.3390/medicina61071309.
2
Evaluation of the effects of thyroid functions on frailty in geriatric patients using the Edmonton, SOF and FRAIL Scales.使用埃德蒙顿量表、SOF量表和衰弱量表评估甲状腺功能对老年患者衰弱的影响。
BMC Geriatr. 2024 Dec 31;24(1):1051. doi: 10.1186/s12877-024-05643-5.
3
Clinical and Biological Markers of Frailty Syndrome in Patients Undergoing Elective Percutaneous Coronary Intervention.

本文引用的文献

1
Frailty and nutritional status in older people: the Mini Nutritional Assessment as a screening tool for the identification of frail subjects.老年人的虚弱和营养状况:Mini Nutritional Assessment 作为识别虚弱个体的筛查工具。
Clin Interv Aging. 2018 Jul 13;13:1237-1244. doi: 10.2147/CIA.S164174. eCollection 2018.
2
Degree of Peripheral Thyroxin Deiodination, Frailty, and Long-Term Survival in Hospitalized Older Patients.外周甲状腺素脱碘程度、虚弱与住院老年患者的长期生存
J Clin Endocrinol Metab. 2018 May 1;103(5):1867-1876. doi: 10.1210/jc.2017-02149.
3
Low FT3: a possible marker of frailty in the elderly.
接受择期经皮冠状动脉介入治疗患者衰弱综合征的临床和生物学标志物
Diagnostics (Basel). 2024 Nov 26;14(23):2663. doi: 10.3390/diagnostics14232663.
4
The association between osteoporosis and frailty: a cross-sectional observational study and mendelian randomization analysis.骨质疏松症与衰弱的相关性:一项横断面观察性研究和孟德尔随机分析。
J Orthop Surg Res. 2024 Jul 9;19(1):398. doi: 10.1186/s13018-024-04875-w.
5
Albumin-to-alkaline phosphatase ratio may be a better predictor of survival than sclerostin, dickkopf-1, osteopontin, osteoprotegerin and osteocalcin.与硬化素、Dickkopf-1、骨桥蛋白、骨保护素和骨钙素相比,白蛋白与碱性磷酸酶的比值可能是更好的生存预测指标。
Heliyon. 2024 Apr 12;10(8):e29639. doi: 10.1016/j.heliyon.2024.e29639. eCollection 2024 Apr 30.
6
A Narrative Review of the Utilisation of the SHARE Frailty Instruments (SHARE-FI and SHARE-FI75+) in the Literature.关于文献中SHARE衰弱量表(SHARE-FI和SHARE-FI75+)应用情况的叙述性综述
J Frailty Sarcopenia Falls. 2023 Dec 1;8(4):221-229. doi: 10.22540/JFSF-08-221. eCollection 2023 Dec.
7
Frailty syndrome in women with osteoporosis, should physicians consider screening? A cross-sectional study.骨质疏松症女性的衰弱综合征,医生应考虑进行筛查吗?一项横断面研究。
Bone Rep. 2023 Oct 31;19:101722. doi: 10.1016/j.bonr.2023.101722. eCollection 2023 Dec.
8
Selected Parameters of Bone Turnover in Neuroendocrine Tumors-A Potential Clinical Use?神经内分泌肿瘤骨转换的选定参数——有潜在临床用途吗?
J Clin Med. 2023 Jul 11;12(14):4608. doi: 10.3390/jcm12144608.
9
Frailty in Aging and the Search for the Optimal Biomarker: A Review.衰老中的衰弱与最佳生物标志物的探寻:综述
Biomedicines. 2022 Jun 16;10(6):1426. doi: 10.3390/biomedicines10061426.
低游离三碘甲状腺原氨酸:老年人虚弱的一个可能标志物。
Clin Interv Aging. 2017 Feb 10;12:335-341. doi: 10.2147/CIA.S125934. eCollection 2017.
4
Inflammation and frailty in the elderly: A systematic review and meta-analysis.老年人的炎症与虚弱:系统评价和荟萃分析。
Ageing Res Rev. 2016 Nov;31:1-8. doi: 10.1016/j.arr.2016.08.006. Epub 2016 Aug 31.
5
Frailty measurement in research and clinical practice: A review.衰弱的研究与临床实践中的测量:综述。
Eur J Intern Med. 2016 Jun;31:3-10. doi: 10.1016/j.ejim.2016.03.007. Epub 2016 Mar 31.
6
Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.瑞典75岁及以上新发髋部骨折老年患者与健康对照者血清中骨转换标志物Dickkopf-1、硬化蛋白、骨保护素、骨桥蛋白、骨钙素和25-羟基维生素D的水平。
J Endocrinol Invest. 2016 Aug;39(8):855-63. doi: 10.1007/s40618-015-0421-5. Epub 2016 Feb 5.
7
Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women.循环骨保护素水平升高与肾功能不全可预测15年心血管疾病及全因死亡率:老年女性前瞻性研究
PLoS One. 2015 Jul 29;10(7):e0134266. doi: 10.1371/journal.pone.0134266. eCollection 2015.
8
The challenges of human population ageing.人口老龄化的挑战。
Age Ageing. 2015 Mar;44(2):185-7. doi: 10.1093/ageing/afu189. Epub 2014 Dec 1.
9
Standard laboratory tests to identify older adults at increased risk of death.用于识别死亡风险增加的老年人的标准实验室检查。
BMC Med. 2014 Oct 7;12:171. doi: 10.1186/s12916-014-0171-9.
10
Association between inflammatory markers and frailty in institutionalized older men.机构养老男性中炎症标志物与衰弱之间的关联。
Maturitas. 2014 Nov;79(3):329-33. doi: 10.1016/j.maturitas.2014.07.014. Epub 2014 Jul 30.